Sort
326,823 grants matching “clinical trial”
Pitt-Ohio State Clinical Trials Unit
$2,355,644John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2022 · AI
Providence/Boston Center for AIDS Research (CFAR)
$2,355,280Susan Cu-Uvin · Miriam Hospital · P30 · FY2021 · AI
FUNCTION BIRN
$2,355,257Steven G Potkin · University Of California-Irvine · U24 · FY2007 · RR
FUNCTION BIRN
$2,355,256Steven G Potkin · University Of California-Irvine · U24 · FY2007 · RR
Chemical biology of innate immunity for treating cancer and autoimmunity
$2,355,000Lingyin Li · Stanford University · DP2 · FY2017 · CA
Efflux pump inhibitors to reduce duration of antituberculosis therapy
$2,355,000Tawanda Gumbo · Ut Southwestern Medical Center · DP2 · FY2007 · OD
Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes
$2,354,817France Carrier · University Of Maryland Baltimore · U19 · FY2024 · AI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,354,716Barbara Burtness · Yale University · P50 · FY2020 · DE
Central Hub for Kidney Precision Medicine - Administrative Core
$2,354,521Jonathan Himmelfarb · University Of Washington · U2C · FY2018 · DK
Molecular Targets Laboratory
$2,354,485James McMahon · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
COORDINATING CENTER FOR AMD PREVENTION TRIAL
$2,354,227University Of Pennsylvania · U10 · FY2005 · EY
IMPACTA PERU CLINICAL TRIALS UNIT
$2,354,219Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2014 · AI
Maternal Omics to Maximize Immunity
$2,353,983Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2025 · AI
Maternal Omics to Maximize Immunity
$2,353,983Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2024 · AI
Maternal Omics to Maximize Immunity
$2,353,983Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2023 · AI
Maternal Omics to Maximize Immunity
$2,353,983Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2022 · AI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
$2,353,868Christopher Parks · International Aids Vaccine Initiative · P01 · FY2019 · AI
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.
$2,353,361Dart Clint · Health Decisions, Inc. · N01 · FY2021 · HD
Psychosis Risk Evaluation, Data Integration and Computational Technologies (PREDICT): Data Processing, Analysis, and Coordination Center
$2,353,360Martha Shenton · Brigham And Women'S Hospital · U24 · FY2023 · MH
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity
$2,353,012Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · AI
Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report
$2,352,906Richard Mauritz Bergenstal · Healthpartners Institute · U01 · FY2025 · DK
Cancer Center Support Grant
$2,352,696Benjamin G. Neel · New York University School Of Medicine · P30 · FY2014 · CA
Senior Leadership
$2,352,617Jennifer A Pietenpol · Vanderbilt University · P30 · FY2012 · CA
Spatial epigenomics: A new framework for overcoming mechanical heterogeneity in solid tumors
$2,352,500Timothy Lamont Downing · University Of California-Irvine · DP2 · FY2019 · CA
Cancer Center Support Grant
$2,352,380Richard A. Van Etten · University Of California-Irvine · P30 · FY2025 · CA